Aurélie Barrail‐Tran

Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8+ T-cells

Caroline Passaes, Delphine Desjardins, Anaïs Chapel et al. · Nature Communications · 2024 · 50 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Effect of Adherence as Measured by MEMS, Ritonavir Boosting, and CYP3A5 Genotype on Atazanavir Pharmacokinetics in Treatment-Naive HIV-Infected Patients

Radojka M. Savić, Aurélie Barrail‐Tran, Xavier Duval et al. · Clinical Pharmacology & Therapeutics · 2012 · 49 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort

Lise Cuzin, Pascal Puglièse, Christine Katlama et al. · Journal of Antimicrobial Chemotherapy · 2018 · 49 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Randomised Pharmacokinetic Trial of Rifabutin with Lopinavir/Ritonavir-Antiretroviral Therapy in Patients with HIV-Associated Tuberculosis in Vietnam

Nguyễn Thị Ngọc Lan, Nguyen Thi Nguyet Thu, Aurélie Barrail‐Tran et al. · PLoS ONE · 2014 · 48 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Inhibition of Adipose Tissue Beiging by HIV Integrase Inhibitors, Dolutegravir and Bictegravir, Is Associated with Adipocyte Hypertrophy, Hypoxia, Elevated Fibrosis, and Insulin Resistance in Simian Adipose Tissue and Human Adipocytes

Kenza Ngono Ayissi, Jennifer Gorwood, Laura Pelletier et al. · Cells · 2022 · 44 citations · Full text

Life Sciences, Pharmacology, Physiology +17